AlbionVC

AlbionVC is a London-based venture capital firm that specializes in seed to Series B investments, focusing on sectors such as healthcare, digital health, medtech, B2B software, SaaS, digital risk, fintech, artificial intelligence, deep tech, and life sciences. With over 20 years of investment experience, AlbionVC manages approximately £500 million in venture funds and has made over 50 technology investments. The firm typically invests between £0.25 million and £10 million, targeting innovative companies in the UK. As a subsidiary of Albion Capital Group LLP, AlbionVC is authorized and regulated by the Financial Conduct Authority, emphasizing its commitment to supporting the growth of technology-driven businesses.

Leigh Brody

Investment Manager

Simon Goldman

Partner

Paul Lehair

Investment Director

Nadine Torbey

Investment Director

Pauline Stasiak Ph.D

Investment Manager

108 past transactions

Accelex

Series A in 2022
Accelex is a data acquisition, analytics, and reporting solutions provider for alternative investors and asset servicers.

Black Swan Data

Venture Round in 2022
Black Swan Data Limited is a London-based company that specializes in data integration and classification, data science, and predictive modeling. Founded in 2011, the company has developed a platform called Nest, which unifies and enriches data for visualization, allowing clients to gain insights into consumer demand influenced by various external factors, such as competitive activity and public events. Black Swan's technology focuses on analyzing both public and private data to predict consumer behavior accurately, helping brands identify untapped opportunities and enhance their marketing effectiveness. By leveraging AI-powered tools, the company aims to transform how businesses utilize data, ultimately creating better outcomes through informed decision-making and innovative solutions.

Ophelos

Seed Round in 2022
Ophelos was created to transform how individuals, families, and businesses manage their financial health.

Speechmatics

Series B in 2022
Speechmatics Limited, founded in 2009 and based in Cambridge, United Kingdom, specializes in developing advanced speech recognition software. The company provides automatic speech recognition technologies that convert voice data into text for various applications, including media broadcasting, contact centers, compliance, e-discovery, and transcription. Utilizing neural networks and the latest advancements in machine learning, Speechmatics has created a robust cloud-based and real-time speech recognition platform that supports multiple languages. This technology can be deployed in various contexts, allowing businesses to gather actionable intelligence and enhance processes while addressing data privacy concerns. By enabling the generation of time-stamped transcripts and insights about customers and employees, Speechmatics aims to improve operational efficiency and contribute positively to the bottom line.

uMotif

Series B in 2022
uMotif Limited is a healthcare technology company that develops a data capture solution designed for clinical research. Founded in 2012 and based in London, uMotif operates a patient-centered platform that facilitates the collection and validation of various forms of patient-generated data, including electronic consent, electronic clinical outcome assessments, and patient-reported outcomes. This platform enables researchers and clinicians to gather comprehensive health data that is essential for medical research, benefiting pharmaceutical companies, medical device manufacturers, biotech firms, contract research organizations, and academic institutions. By enhancing the data collection process, uMotif supports the advancement of clinical research across diverse health conditions.

TransFICC

Venture Round in 2022
TransFICC Limited is a technology company based in London, specializing in e-trading solutions for the fixed income and derivatives markets. Founded in 2016, it addresses the fragmentation in these markets by providing a unified application programming interface (API) that consolidates multiple execution venue APIs into a single connection. This enables banks and asset managers to efficiently manage their trading activities while maintaining low latency and secure connectivity essential for real-time trading. TransFICC's platform supports microsecond timestamping for data, which is crucial for maintaining a comprehensive audit trail and ensuring compliance with best execution standards. The company’s cloud-based hosting services facilitate timely updates and adaptations to changes in trading venues, making it a valuable partner for clients navigating the complexities of modern trading environments.

PerchPeek

Series A in 2022
PerchPeek uses AI to guide people through every stage of their relocation from search to settling in. It serves as an AI-powered home search assistant that makes it easier for flat-hunters to find a new home. The company was founded in 2017 and based in London, England.

brytlyt

Series A in 2021
Brytlyt Limited is a company based in Maidstone, United Kingdom, that specializes in developing a high-performance GPU database and analytics platform. Founded in 2013, Brytlyt offers products such as its primary database and analytics tool, Brytlyt, and SpotLyt, which provides interactive analytics for row datasets. The company's unique patented algorithms, combined with advanced hardware, enable it to deliver exceptional performance and return on investment for Big Data applications.

Elliptic

Series C in 2021
Elliptic Enterprises Limited, based in London, operates a platform focused on enhancing the transparency and accountability of cryptocurrency transactions. Established in 2013, the company offers blockchain analytics and compliance solutions that help financial institutions, cryptocurrency companies, and government agencies manage financial crime risk and fulfill regulatory requirements. Elliptic provides actionable intelligence to identify and combat illicit activities within the cryptocurrency space, thereby contributing to the integrity of digital currencies. The company also offers Elliptic Vault, a secure storage service for bitcoins, and is involved in lobbying, education, and advocacy related to digital currencies. By addressing the critical challenge of identity verification in cryptocurrencies, Elliptic aims to prevent criminals from undermining the positive potential of this technology.

Imandra

Seed Round in 2021
Imandra, developed by Aesthetic Integration Ltd., is a cloud-scale automated reasoning system designed to enhance the rigor and governance of critical algorithms, particularly within the financial industry. Founded in 2014 and based in London, the company focuses on formal verification technology that enables the analysis and sharing of trading system specifications. Imandra provides tools that not only analyze algorithms but also assist in identifying and resolving software bugs, ensuring that the algorithms are safe, explainable, and fair. As reliance on complex software increases, Imandra's Reasoning as a Service platform aims to address the need for deep advancements in artificial intelligence to maintain the integrity of essential systems.

Oviva

Series C in 2021
Oviva is a digital health company providing medically-oriented nutritional counseling services in Switzerland, Germany, and the United Kingdom. Founded in 2013 and headquartered in Ingenbohl, Switzerland, Oviva offers personalized behavior change programs aimed at managing diet and lifestyle-related health issues like obesity and diabetes. Their services are delivered through a network of qualified dietitians who work with clients both in clinics and remotely. The company has developed a smartphone application that allows users to engage with their dietitian, maintain a food diary, set health goals, and access tailored educational materials. This technology-enabled approach helps patients achieve better health outcomes while reducing the need for in-person appointments, ultimately lowering healthcare costs by preventing complications associated with these conditions.

Gravitee

Series A in 2021
Gravitee.io develops an open-source API management platform that assists organizations in securing, publishing, and analyzing their APIs. The platform provides a user-friendly environment that consolidates various API management functions, including analytics dashboards, a developer portal, identity and access management, and security access tools. These features enable businesses to design, manage, deploy, and monitor their APIs in a secure and governed manner. Gravitee's solution is designed to be cost-effective, allowing organizations to access a comprehensive and secure interface for their API needs without incurring significant expenses.

Quantexa

Series D in 2021
Quantexa Limited is an information technology company based in London, specializing in entity resolution and network building technology. Founded in 2016, Quantexa offers solutions that include comprehensive customer and network views, fraud detection, compliance, anti-money laundering, and surveillance. The company's technology leverages real-time entity resolution, network analytics, and artificial intelligence to integrate diverse data sets and enhance decision-making for its clients. Quantexa serves a global clientele across various sectors, including financial services, corporate, and public institutions, and has established a strategic alliance with Accenture. The company operates internationally with offices in the UK, Brussels, New York, Boston, and Sydney.

NuvoAir

Series A in 2021
NuvoAir AB develops Air Next home spirometer, a medical device to monitor lung function. It offers its products online. The company was founded in 2015 and is based in Stockholm, Sweden.

Accelex

Seed Round in 2021
Accelex is a data acquisition, analytics, and reporting solutions provider for alternative investors and asset servicers.

Healios

Series A in 2021
Healios Limited, founded in 2013 and based in Southampton, United Kingdom, operates an online platform that facilitates video calls between mental health therapists and patients, including both children and adults. The company focuses on enhancing the delivery of mental health care by integrating technology with specialized expertise and personal connections. Healios aims to empower patients and families affected by mental and physical illnesses through innovative family intervention and behavioral change techniques that extend beyond traditional treatment settings. By fostering a deeper understanding of mental health and promoting healthier habits, Healios seeks to improve patient outcomes and enhance the quality of life for individuals and their families.

Panaseer

Series B in 2021
Panaseer Limited develops a cloud-based cybersecurity intelligence platform that assists enterprise security teams in making informed risk decisions. Founded in 2014 and headquartered in London, with an office in New York, the company offers the Panaseer Security Data Lake, which provides real-time insights into an organization's assets, applications, users, and data sets. This platform identifies gaps in security controls and aligns them with industry standards while facilitating regulatory compliance. By ingesting data from various sources, both cloud-based and on-premises, Panaseer enables organizations to monitor and analyze their cybersecurity posture effectively. The platform automates reporting processes, tailoring insights for stakeholders at different levels, thereby enhancing decision-making across the organization. Security leaders utilize Panaseer’s capabilities to prioritize risks based on their potential impact on the business and optimize overall cyber hygiene practices.

Solidatus

Series A in 2021
Solidatus is a developer of data management software that enables organizations to effectively understand and visualize the flow of data within their systems. Through its intuitive web-based application, Solidatus allows users to rapidly create and share comprehensive data maps, which are essential for supporting regulatory compliance, such as GDPR, and simplifying complex system landscapes. The software facilitates digital transformation by helping companies govern their data, migrate to cloud-based solutions, and generate necessary regulatory reports. By prioritizing usability and speed, Solidatus offers a unique approach to mapping and managing data assets, empowering organizations to leverage their data more efficiently.

Limitless

Series B in 2021
Limitless Technology Ltd, founded in 2016 and based in London, develops an AI-powered platform that enhances customer service engagements. This platform allows businesses to connect customers with qualified experts to address inquiries on-demand, offering a faster and more cost-effective service. By leveraging customer interactions and feedback, the system continually improves through AI, automating responses to lower-value queries over time. Limitless operates in over 20 countries and serves notable clients such as Microsoft, Unilever, and Sage. The company is backed by investors including Unilever Ventures, Downing Ventures, and Albion Capital.

Umedeor

Seed Round in 2020
Umedeor Ltd is a London-based company that has developed a technology platform designed to streamline data access for medical research and healthcare delivery. Founded in 2017, Umedeor enables healthcare providers, research organizations, and care agencies to manage and monitor medical records effectively. The platform automates the creation of prospective patient registries, allowing healthcare sites to participate in multiple research programs simultaneously without adding extra workload for staff. Additionally, Umedeor provides life science companies with access to high-quality data, facilitating compliant patient engagement to support research and development initiatives as well as post-market activities. Umedeor also has a presence in New York, expanding its reach within the healthcare sector.

Runa

Series A in 2020
Businesses from every walk of life use rewards to acquire, retain and thank customers but the current process is broken. Sending rewards, incentives and non-cash payouts is manual, expensive, time-consuming and error-prone. WeGift changes this. Operating in more than 30 countries, in 22 languages, 20 currencies, with over 700 brand partners, and hundreds of clients, like Perkbox, Sodexo, New Look and Halfords among others, WeGift’s cloud-based, open API solutions allow businesses to transfer value to consumers, in real-time and globally. Established in 2016, WeGift is backed by leading entrepreneurs and investors.

Seldon

Series A in 2020
Seldon Technologies Ltd. is a company based in Shoreditch, United Kingdom, that specializes in open-source machine learning deployment. Founded in 2014, Seldon offers a platform called Seldon Deploy, which facilitates the transition from research and development to production for machine learning engineering teams, achieving efficiency gains of up to 84%. The platform provides essential features such as audit trails, compliance approvals, and detailed model explanations. Seldon's open-source projects are recognized for their excellence in model serving, monitoring, and explanations, with over 2.5 million installations and 250,000 models deployed. The company serves a diverse clientele, including major enterprises in technology, pharmaceuticals, automotive, finance, and retail, and its solutions are integrated with leading machine learning platforms from companies like Google and Red Hat. Seldon has also garnered recognition as a "Cool Vendor" in AI Core technologies by Gartner in 2020.

uMotif

Series A in 2020
uMotif Limited is a healthcare technology company that develops a data capture solution designed for clinical research. Founded in 2012 and based in London, uMotif operates a patient-centered platform that facilitates the collection and validation of various forms of patient-generated data, including electronic consent, electronic clinical outcome assessments, and patient-reported outcomes. This platform enables researchers and clinicians to gather comprehensive health data that is essential for medical research, benefiting pharmaceutical companies, medical device manufacturers, biotech firms, contract research organizations, and academic institutions. By enhancing the data collection process, uMotif supports the advancement of clinical research across diverse health conditions.

Quantexa

Series C in 2020
Quantexa Limited is an information technology company based in London, specializing in entity resolution and network building technology. Founded in 2016, Quantexa offers solutions that include comprehensive customer and network views, fraud detection, compliance, anti-money laundering, and surveillance. The company's technology leverages real-time entity resolution, network analytics, and artificial intelligence to integrate diverse data sets and enhance decision-making for its clients. Quantexa serves a global clientele across various sectors, including financial services, corporate, and public institutions, and has established a strategic alliance with Accenture. The company operates internationally with offices in the UK, Brussels, New York, Boston, and Sydney.

TransFICC

Series A in 2020
TransFICC Limited is a technology company based in London, specializing in e-trading solutions for the fixed income and derivatives markets. Founded in 2016, it addresses the fragmentation in these markets by providing a unified application programming interface (API) that consolidates multiple execution venue APIs into a single connection. This enables banks and asset managers to efficiently manage their trading activities while maintaining low latency and secure connectivity essential for real-time trading. TransFICC's platform supports microsecond timestamping for data, which is crucial for maintaining a comprehensive audit trail and ensuring compliance with best execution standards. The company’s cloud-based hosting services facilitate timely updates and adaptations to changes in trading venues, making it a valuable partner for clients navigating the complexities of modern trading environments.

TransFICC

Series A in 2020
TransFICC Limited is a technology company based in London, specializing in e-trading solutions for the fixed income and derivatives markets. Founded in 2016, it addresses the fragmentation in these markets by providing a unified application programming interface (API) that consolidates multiple execution venue APIs into a single connection. This enables banks and asset managers to efficiently manage their trading activities while maintaining low latency and secure connectivity essential for real-time trading. TransFICC's platform supports microsecond timestamping for data, which is crucial for maintaining a comprehensive audit trail and ensuring compliance with best execution standards. The company’s cloud-based hosting services facilitate timely updates and adaptations to changes in trading venues, making it a valuable partner for clients navigating the complexities of modern trading environments.

Concirrus

Series B in 2020
Concirrus Ltd. operates a cloud-based platform that connects various data sources and devices, enabling the management and organization of information from products and machines linked through the Internet. Founded in 2012, the company specializes in leveraging Internet of Things (IoT) data to transform businesses across multiple sectors, including healthcare, security, mining, insurance, and energy. Concirrus offers a range of custom solutions, including consultancy, planning, implementation, and support services, alongside pre-built applications for asset security, fleet management, smart energy, and patient monitoring. Their focus extends to providing insights and rating factors for the insurance industry, employing advanced analytics and machine learning to enhance risk management and operational efficiency. Additionally, Concirrus operates an incident monitoring center for theft recovery and asset security. The company is headquartered in London and has established strategic partnerships to further its technological offerings.

Hazy

Seed Round in 2020
Hazy Limited is a London-based company that specializes in automatic data anonymization using artificial intelligence. Incorporated in 2017, Hazy develops a platform that generates synthetic data, which retains the statistical properties of real datasets while ensuring the privacy and confidentiality of personal information. This innovative approach allows businesses to share and utilize data for analytics and innovation without the risks associated with compliance and security breaches. By capturing patterns from raw data, Hazy creates entirely synthetic datasets that provide the statistical value of the original data, enabling data-centric organizations to unlock their data potential more safely and efficiently. Hazy is recognized as a spin-out from University College London and has garnered backing from prominent partners such as Microsoft and Nationwide.

Hussle

Series A in 2020
Hussle is the smart new way to fit fitness into your life. We partner with amazing gyms across the UK. When you Hussle, you can go to any of these gyms. There are no contracts, no inductions, no sign-up fees. Just thousands of gyms, pools and spas – wherever you are, whenever you want to go. So when you Hussle, you can make fitness a part of your day, not a pause in it. Hussle. Make life work out.

Oviva

Series B in 2020
Oviva is a digital health company providing medically-oriented nutritional counseling services in Switzerland, Germany, and the United Kingdom. Founded in 2013 and headquartered in Ingenbohl, Switzerland, Oviva offers personalized behavior change programs aimed at managing diet and lifestyle-related health issues like obesity and diabetes. Their services are delivered through a network of qualified dietitians who work with clients both in clinics and remotely. The company has developed a smartphone application that allows users to engage with their dietitian, maintain a food diary, set health goals, and access tailored educational materials. This technology-enabled approach helps patients achieve better health outcomes while reducing the need for in-person appointments, ultimately lowering healthcare costs by preventing complications associated with these conditions.

Speechmatics

Series A in 2019
Speechmatics Limited, founded in 2009 and based in Cambridge, United Kingdom, specializes in developing advanced speech recognition software. The company provides automatic speech recognition technologies that convert voice data into text for various applications, including media broadcasting, contact centers, compliance, e-discovery, and transcription. Utilizing neural networks and the latest advancements in machine learning, Speechmatics has created a robust cloud-based and real-time speech recognition platform that supports multiple languages. This technology can be deployed in various contexts, allowing businesses to gather actionable intelligence and enhance processes while addressing data privacy concerns. By enabling the generation of time-stamped transcripts and insights about customers and employees, Speechmatics aims to improve operational efficiency and contribute positively to the bottom line.

Elliptic

Series B in 2019
Elliptic Enterprises Limited, based in London, operates a platform focused on enhancing the transparency and accountability of cryptocurrency transactions. Established in 2013, the company offers blockchain analytics and compliance solutions that help financial institutions, cryptocurrency companies, and government agencies manage financial crime risk and fulfill regulatory requirements. Elliptic provides actionable intelligence to identify and combat illicit activities within the cryptocurrency space, thereby contributing to the integrity of digital currencies. The company also offers Elliptic Vault, a secure storage service for bitcoins, and is involved in lobbying, education, and advocacy related to digital currencies. By addressing the critical challenge of identity verification in cryptocurrencies, Elliptic aims to prevent criminals from undermining the positive potential of this technology.

Koru Kids

Series A in 2019
Koru Kids Ltd. is a childcare service provider based in London, United Kingdom, specializing in nanny sharing arrangements. Founded in 2016, the company connects families who have a full-time nanny with those seeking part-time childcare, primarily in Greater London. Koru Kids aims to improve childcare options by facilitating these shared arrangements, which can reduce costs for families while providing flexible care solutions. The team behind Koru Kids possesses backgrounds in childcare, healthcare, and technology startups, indicating a diverse expertise in addressing the needs of modern families. The company is registered with the Information Commissioner's Office and is affiliated with the Financial Conduct Authority's Innovation Hub.

Clear Review

Series A in 2019
Clear Review Limited is a London-based company that offers a cloud-based performance management and engagement platform designed for small and medium-sized enterprises. The platform facilitates frequent employee feedback and continuous conversations between employees and managers. Key services include check-ins, real-time feedback, aligned SMART objectives, performance reviews, personal development plans, and comprehensive reporting tools, all supported by video guidance. Clear Review serves a diverse range of sectors, including media, technology, financial services, healthcare, government, education, and professional services. Originally established as One Touch Apps Limited in 2014, the company rebranded to Clear Review Limited in August 2019.

Symetrica

Venture Round in 2019
Symetrica Ltd. provides integrated radiation detection and identification technologies for custom organizations and government departments worldwide. Its technology for homeland security include gamma-ray detection and identification sub-systems; helium-3 neutron detector technology; and spectroscopic PVT detector systems. The company serves the military and homeland security markets. Symetrica Ltd. was founded in 2002 and is based in Southampton, United Kingdom with additional office in Maynard, Massachusetts.

Astroscreen

Seed Round in 2019
Astroscreen protects brands and defends democracy from harmful social media manipulation campaigns also known as astroturfing.

Imandra

Seed Round in 2019
Imandra, developed by Aesthetic Integration Ltd., is a cloud-scale automated reasoning system designed to enhance the rigor and governance of critical algorithms, particularly within the financial industry. Founded in 2014 and based in London, the company focuses on formal verification technology that enables the analysis and sharing of trading system specifications. Imandra provides tools that not only analyze algorithms but also assist in identifying and resolving software bugs, ensuring that the algorithms are safe, explainable, and fair. As reliance on complex software increases, Imandra's Reasoning as a Service platform aims to address the need for deep advancements in artificial intelligence to maintain the integrity of essential systems.

Limitless

Series A in 2019
Limitless Technology Ltd, founded in 2016 and based in London, develops an AI-powered platform that enhances customer service engagements. This platform allows businesses to connect customers with qualified experts to address inquiries on-demand, offering a faster and more cost-effective service. By leveraging customer interactions and feedback, the system continually improves through AI, automating responses to lower-value queries over time. Limitless operates in over 20 countries and serves notable clients such as Microsoft, Unilever, and Sage. The company is backed by investors including Unilever Ventures, Downing Ventures, and Albion Capital.

Avora

Series A in 2019
Avora is a cloud-based business intelligence platform that leverages artificial intelligence and machine learning to enhance data analysis for organizations across various industries, including retail, financial services, and advertising. The platform simplifies the process of extracting valuable insights from data by allowing non-technical users to generate and share reports effortlessly, thus removing barriers to data accessibility. Avora's technology consolidates data from numerous sources and accelerates the time to insight, significantly reducing data preparation and discovery time by 50-80%. It also features automated anomaly detection, enabling businesses to respond proactively to potential issues. Headquartered in London, with additional offices in New York and Romania, Avora empowers companies to make informed decisions quickly, ultimately driving productivity and positive change.

Egress

Series C in 2018
Egress Software Technologies Ltd. specializes in cloud-based email and file encryption solutions aimed at securely sharing confidential information across various sectors, including public services, healthcare, education, and financial services. Founded in 2007 and headquartered in London, the company offers a range of products such as desktop, mobile, and gateway encryption, as well as secure web forms. Its human-layer security platform employs advanced contextual machine learning and encryption technologies to prevent data breaches, providing organizations with tools to manage unstructured data effectively. Egress aims to enhance email security, ensuring compliance with regulatory standards and improving productivity for small, mid-sized, and enterprise-level organizations. With offices in London, Sheffield, Boston, and Toronto, Egress serves a global clientele, including individual users and large commercial entities.

Epsilogen

Series A in 2018
IGEM Therapeutics is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.The company's offerings include IgE-based drugs targeting solid tumors, enabling patients to kill parasites which reside in human tissue, also the home of the solid tumor.

Raremark

Series A in 2018
Raremark builds online communities in rare, medical conditions so patients and their families can learn from the experiences of others like them, participate in clinical trials, and share their experience of new treatments. The company's vision is a world in which all rare conditions are treated.

Pando

Seed Round in 2018
Pando is an essential tool for teamwork and secure collaboration. It is designed to benefit anyone working in health and social care, working in a team, with a need to share sensitive information and images securely.

Locum's Nest

Venture Round in 2018
Locum's Nest is an online recruitment platform that transforms the recruitment process for locum staff in the NHS. By streamlining the connection between doctors and locum work in hospitals, the platform enables healthcare facilities to efficiently manage locum shifts and maintain essential documentation in one central location. It offers features such as customized job searches, automated record-keeping, and the ability to build vacancy portfolios, ultimately facilitating the hiring of temporary workers. This innovative approach aims to reduce reliance on external agencies and lower costs associated with locum staffing, addressing the financial pressures faced by the NHS while improving the overall recruitment experience.

Arecor

Venture Round in 2018
Arecor Limited is a biopharmaceutical company based in Cambridge, United Kingdom, specializing in the development of innovative stabilization technology solutions for pharmaceutical and biotech firms. The company partners with these organizations to enhance the commercial value and utility of proteins used in various applications, including vaccines, therapeutic proteins, and treatments for complex diseases. Arecor focuses on developing products for areas such as diabetes, oncology, immunology, and infectious diseases, working to reformulate existing therapies to improve their efficacy and ease of use. Its innovative formulation technology enables high concentrations of antibodies for at-home self-administration and stable liquid formulations for biological therapies. Arecor also addresses challenges related to protein degradation and stability, particularly in the formulation of growth hormones and vaccines. Founded in 2006, Arecor operates primarily in the UK and has a global reach, collaborating with leading pharmaceutical and biotech companies to deliver enhanced therapeutic solutions.

Phrasee

Series A in 2018
Phrasee Ltd. is a London-based company specializing in artificial intelligence-driven marketing language generation. Founded in 2015, Phrasee has developed advanced technology that predicts audience emotional responses and generates effective marketing copy. Its Natural Language Generation system can produce millions of human-like variations, optimizing subject lines for emails, body copy, trigger campaigns, and calls-to-action. By analyzing extensive language data, Phrasee's algorithms ensure that the generated content is tailored to specific brands, enhancing engagement and driving conversions. The company's innovative approach aims to revolutionize digital marketing by leveraging AI to create compelling language that outperforms traditional human-generated copy.

Quantexa

Series B in 2018
Quantexa Limited is an information technology company based in London, specializing in entity resolution and network building technology. Founded in 2016, Quantexa offers solutions that include comprehensive customer and network views, fraud detection, compliance, anti-money laundering, and surveillance. The company's technology leverages real-time entity resolution, network analytics, and artificial intelligence to integrate diverse data sets and enhance decision-making for its clients. Quantexa serves a global clientele across various sectors, including financial services, corporate, and public institutions, and has established a strategic alliance with Accenture. The company operates internationally with offices in the UK, Brussels, New York, Boston, and Sydney.

Hazy

Seed Round in 2018
Hazy Limited is a London-based company that specializes in automatic data anonymization using artificial intelligence. Incorporated in 2017, Hazy develops a platform that generates synthetic data, which retains the statistical properties of real datasets while ensuring the privacy and confidentiality of personal information. This innovative approach allows businesses to share and utilize data for analytics and innovation without the risks associated with compliance and security breaches. By capturing patterns from raw data, Hazy creates entirely synthetic datasets that provide the statistical value of the original data, enabling data-centric organizations to unlock their data potential more safely and efficiently. Hazy is recognized as a spin-out from University College London and has garnered backing from prominent partners such as Microsoft and Nationwide.

uMotif

Venture Round in 2018
uMotif Limited is a healthcare technology company that develops a data capture solution designed for clinical research. Founded in 2012 and based in London, uMotif operates a patient-centered platform that facilitates the collection and validation of various forms of patient-generated data, including electronic consent, electronic clinical outcome assessments, and patient-reported outcomes. This platform enables researchers and clinicians to gather comprehensive health data that is essential for medical research, benefiting pharmaceutical companies, medical device manufacturers, biotech firms, contract research organizations, and academic institutions. By enhancing the data collection process, uMotif supports the advancement of clinical research across diverse health conditions.

Panaseer

Series A in 2018
Panaseer Limited develops a cloud-based cybersecurity intelligence platform that assists enterprise security teams in making informed risk decisions. Founded in 2014 and headquartered in London, with an office in New York, the company offers the Panaseer Security Data Lake, which provides real-time insights into an organization's assets, applications, users, and data sets. This platform identifies gaps in security controls and aligns them with industry standards while facilitating regulatory compliance. By ingesting data from various sources, both cloud-based and on-premises, Panaseer enables organizations to monitor and analyze their cybersecurity posture effectively. The platform automates reporting processes, tailoring insights for stakeholders at different levels, thereby enhancing decision-making across the organization. Security leaders utilize Panaseer’s capabilities to prioritize risks based on their potential impact on the business and optimize overall cyber hygiene practices.

Healios

Venture Round in 2018
Healios Limited, founded in 2013 and based in Southampton, United Kingdom, operates an online platform that facilitates video calls between mental health therapists and patients, including both children and adults. The company focuses on enhancing the delivery of mental health care by integrating technology with specialized expertise and personal connections. Healios aims to empower patients and families affected by mental and physical illnesses through innovative family intervention and behavioral change techniques that extend beyond traditional treatment settings. By fostering a deeper understanding of mental health and promoting healthier habits, Healios seeks to improve patient outcomes and enhance the quality of life for individuals and their families.

Hussle

Series A in 2018
Hussle is the smart new way to fit fitness into your life. We partner with amazing gyms across the UK. When you Hussle, you can go to any of these gyms. There are no contracts, no inductions, no sign-up fees. Just thousands of gyms, pools and spas – wherever you are, whenever you want to go. So when you Hussle, you can make fitness a part of your day, not a pause in it. Hussle. Make life work out.

Koru Kids

Seed Round in 2018
Koru Kids Ltd. is a childcare service provider based in London, United Kingdom, specializing in nanny sharing arrangements. Founded in 2016, the company connects families who have a full-time nanny with those seeking part-time childcare, primarily in Greater London. Koru Kids aims to improve childcare options by facilitating these shared arrangements, which can reduce costs for families while providing flexible care solutions. The team behind Koru Kids possesses backgrounds in childcare, healthcare, and technology startups, indicating a diverse expertise in addressing the needs of modern families. The company is registered with the Information Commissioner's Office and is affiliated with the Financial Conduct Authority's Innovation Hub.

MeiraGTx

Venture Round in 2017
MeiraGTx is a clinical-stage gene therapy company dedicated to developing and commercializing innovative gene therapy products aimed at transforming the lives of patients with acquired and inherited disorders. The company has a diverse pipeline that includes several ongoing clinical programs focused primarily on treating conditions related to the eye, salivary gland, and central nervous system. Key product candidates include AAV-CNGB3, AAV-CNGA3, and AAV-RPGR, among others. MeiraGTx operates in the United States, the United Kingdom, and the European Union, leveraging its expertise in viral vector design and gene therapy manufacturing. With a portfolio approach to technology development, the company plans to expand its focus to include additional gene therapy treatments for various serious diseases in the future.

Oviva

Series A in 2017
Oviva is a digital health company providing medically-oriented nutritional counseling services in Switzerland, Germany, and the United Kingdom. Founded in 2013 and headquartered in Ingenbohl, Switzerland, Oviva offers personalized behavior change programs aimed at managing diet and lifestyle-related health issues like obesity and diabetes. Their services are delivered through a network of qualified dietitians who work with clients both in clinics and remotely. The company has developed a smartphone application that allows users to engage with their dietitian, maintain a food diary, set health goals, and access tailored educational materials. This technology-enabled approach helps patients achieve better health outcomes while reducing the need for in-person appointments, ultimately lowering healthcare costs by preventing complications associated with these conditions.

Locum's Nest

Venture Round in 2017
Locum's Nest is an online recruitment platform that transforms the recruitment process for locum staff in the NHS. By streamlining the connection between doctors and locum work in hospitals, the platform enables healthcare facilities to efficiently manage locum shifts and maintain essential documentation in one central location. It offers features such as customized job searches, automated record-keeping, and the ability to build vacancy portfolios, ultimately facilitating the hiring of temporary workers. This innovative approach aims to reduce reliance on external agencies and lower costs associated with locum staffing, addressing the financial pressures faced by the NHS while improving the overall recruitment experience.

Panaseer

Seed Round in 2017
Panaseer Limited develops a cloud-based cybersecurity intelligence platform that assists enterprise security teams in making informed risk decisions. Founded in 2014 and headquartered in London, with an office in New York, the company offers the Panaseer Security Data Lake, which provides real-time insights into an organization's assets, applications, users, and data sets. This platform identifies gaps in security controls and aligns them with industry standards while facilitating regulatory compliance. By ingesting data from various sources, both cloud-based and on-premises, Panaseer enables organizations to monitor and analyze their cybersecurity posture effectively. The platform automates reporting processes, tailoring insights for stakeholders at different levels, thereby enhancing decision-making across the organization. Security leaders utilize Panaseer’s capabilities to prioritize risks based on their potential impact on the business and optimize overall cyber hygiene practices.

MPP Global

Series B in 2017
MPP Global Solutions Ltd., trading as MPP Global, develops and provides integrated cloud identity management, customer relationship management (CRM), and ecommerce solutions through its eSuite platform. Additionally, it offers metering, marketing, promotion, billing, payment, subscription, reporting, and analytics solutions. The company caters to television, media, publishing, and entertainment industries. Its clientele include Sky, The Times, L''Equipe, The Daily Mail, el Mundo, el Tiempo, Local Media Group, The Irish Times, TP Vision, and Universal Music Group. MPP Global Solutions Ltd. was founded in 2000 and is headquartered in Warrington, United Kingdom with additional offices in Europe, United States, South America, and Australia.

Quantexa

Series A in 2017
Quantexa Limited is an information technology company based in London, specializing in entity resolution and network building technology. Founded in 2016, Quantexa offers solutions that include comprehensive customer and network views, fraud detection, compliance, anti-money laundering, and surveillance. The company's technology leverages real-time entity resolution, network analytics, and artificial intelligence to integrate diverse data sets and enhance decision-making for its clients. Quantexa serves a global clientele across various sectors, including financial services, corporate, and public institutions, and has established a strategic alliance with Accenture. The company operates internationally with offices in the UK, Brussels, New York, Boston, and Sydney.

Convertr

Series A in 2016
Convertr Media Limited operates Convertr, a cloud-based customer acquisition platform designed for brands, publishers, and agencies in both consumer and B2B markets. Founded in 2011 and headquartered in London, the platform facilitates multi-channel acquisition campaigns by leveraging customer data to enhance sales and provide real-time return on investment. It aids advertisers in driving campaigns, assists publishers in refining audience profiles to boost revenue, and enables agencies to automate client acquisition efforts while reducing workload. Convertr functions as an API-first data optimization tool, ensuring that marketing databases remain efficient by filtering and enhancing data to maintain accuracy and compliance. The platform integrates seamlessly with CRM, marketing automation, and programmatic advertising systems, providing comprehensive solutions for customer acquisition management and automated lead management.

SBD Automotive

Venture Round in 2016
SBD Automotive is an automotive technology platform that specializes in providing independent research, evaluation, and strategic services to car manufacturers. The company focuses on areas such as connected car telematics, vehicle security, and the development of autonomous vehicles and Advanced Driver-Assistance Systems (ADAS). SBD Automotive offers analytical reports, system usability testing, and end-user surveys, enabling the automotive industry to gain insights into technical and market trends. Additionally, they provide industry and market forecasts, as well as competitor benchmarking, to help clients navigate the complexities of automotive technology and enhance their decision-making processes. Through these services, SBD Automotive supports the development of safe and sustainable mobility solutions.

Achilles Therapeutics

Seed Round in 2016
Achilles Therapeutics Ltd. is a biopharmaceutical company based in London, United Kingdom, focused on developing patient-specific immunotherapies to treat cancer. Founded in 2016, the company creates personalized vaccines and T cell therapies that harness the immune system to target and eliminate cancer cells. By identifying truncal tumor neo-antigens and other cancer-specific markers, Achilles Therapeutics aims to develop next-generation therapies that selectively attack tumors while sparing healthy tissues. Currently, the company is conducting two clinical trials: the CHIRON trial for patients with non-small-cell lung cancer and the THETIS trial for those with recurrent or metastatic melanoma.

Black Swan Data

Series B in 2016
Black Swan Data Limited is a London-based company that specializes in data integration and classification, data science, and predictive modeling. Founded in 2011, the company has developed a platform called Nest, which unifies and enriches data for visualization, allowing clients to gain insights into consumer demand influenced by various external factors, such as competitive activity and public events. Black Swan's technology focuses on analyzing both public and private data to predict consumer behavior accurately, helping brands identify untapped opportunities and enhance their marketing effectiveness. By leveraging AI-powered tools, the company aims to transform how businesses utilize data, ultimately creating better outcomes through informed decision-making and innovative solutions.

Orchard Therapeutics

Series A in 2016
Orchard Therapeutics is a biopharmaceutical company based in London, focused on developing innovative gene therapies for serious and life-threatening rare diseases. Operating in the United Kingdom, European Union, and the United States, Orchard employs an autologous ex vivo gene therapy approach to transform patients’ hematopoietic stem cells into gene-modified products for treatment through a single administration. Its portfolio includes Strimvelis, the first approved gene therapy for adenosine deaminase-severe combined immunodeficiency (ADA-SCID), along with several products in clinical development targeting metachromatic leukodystrophy, Wiskott-Aldrich syndrome, X-linked chronic granulomatous disease, and transfusion-dependent beta-thalassemia. The company also has a robust preclinical pipeline addressing various mucopolysaccharidosis types. Orchard collaborates with leading institutions in gene therapy, enhancing its research capabilities and clinical programs. Founded in 2015, Orchard Therapeutics continues to demonstrate a commitment to transforming the lives of patients through its advanced therapies.

InCrowd Sports

Seed Round in 2016
InCrowd Sports Limited, based in London, specializes in developing mobile applications aimed at enhancing fan engagement within sports stadiums. Founded in 2014, the company provides a platform that delivers real-time content, match analysis, and interactive gamification tools, including quizzes and predictive games. This technology not only improves connectivity for fans during events but also allows sports clubs and sponsors to create mobile sponsorship inventory, enabling more effective engagement with audiences. InCrowd Sports combines expertise from various sectors to significantly enrich the in-stadia experience, fostering a deeper connection between fans and the sporting events they attend.

Grapeshot

Series C in 2016
Grapeshot Limited is a software company that specializes in providing marketing and advertising solutions through its Contextual Intelligence Platform. Founded in 2002 and headquartered in Cambridge, United Kingdom, Grapeshot offers tools for real-time targeting, audience discovery, and data enrichment, which aid brands, media agencies, and publishers in enhancing their advertising strategies. Its services include custom targeting, predictive targeting, brand safety, GDPR compliance, and campaign analytics. The platform enables users to improve media efficiency, increase customer engagement, and elevate brand perception by leveraging actionable data to identify revenue-driving behaviors. Grapeshot has received multiple accolades for its innovations, including recognition as a leading publisher tool and attribution solution. The company operates globally, with offices in major cities such as London, New York, Chicago, Los Angeles, Singapore, Toronto, Hong Kong, Shanghai, and Sydney. In 2018, Grapeshot became a subsidiary of Oracle Corporation.

Panaseer

Seed Round in 2015
Panaseer Limited develops a cloud-based cybersecurity intelligence platform that assists enterprise security teams in making informed risk decisions. Founded in 2014 and headquartered in London, with an office in New York, the company offers the Panaseer Security Data Lake, which provides real-time insights into an organization's assets, applications, users, and data sets. This platform identifies gaps in security controls and aligns them with industry standards while facilitating regulatory compliance. By ingesting data from various sources, both cloud-based and on-premises, Panaseer enables organizations to monitor and analyze their cybersecurity posture effectively. The platform automates reporting processes, tailoring insights for stakeholders at different levels, thereby enhancing decision-making across the organization. Security leaders utilize Panaseer’s capabilities to prioritize risks based on their potential impact on the business and optimize overall cyber hygiene practices.

Hussle

Series A in 2015
Hussle is the smart new way to fit fitness into your life. We partner with amazing gyms across the UK. When you Hussle, you can go to any of these gyms. There are no contracts, no inductions, no sign-up fees. Just thousands of gyms, pools and spas – wherever you are, whenever you want to go. So when you Hussle, you can make fitness a part of your day, not a pause in it. Hussle. Make life work out.

Abcodia

Series B in 2015
Abcodia Ltd. is a company focused on the discovery and validation of molecular biomarkers for disease diagnosis and screening. Established in 2010 and based in London, it offers the Roca Test, a solution for the early detection of ovarian cancer, available to customers across various states in the United States as well as in the United Kingdom. Abcodia utilizes a unique longitudinal serum biobank and collaborates with prominent institutions and diagnostic companies to enhance the diagnostic development process. Through these efforts, the company aims to improve disease detection and contribute to better health outcomes.

Aridhia

Venture Round in 2014
Aridhia Informatics Ltd. is a Glasgow-based company that specializes in providing biomedical informatics and analytic solutions aimed at enhancing the understanding and management of chronic diseases. Established in 2007, Aridhia offers a cloud-based platform that supports patient tracking, infection control, and long-term condition management. The company's services include clinical dashboards that present at-a-glance information for healthcare professionals, researchers, and policy makers, facilitating informed decision-making in clinical care. Through strategic partnerships with organizations such as GoPivotal and Glencoe Software, Aridhia aims to integrate patient, clinical, and genomic data to empower patients and inform public health initiatives. The multidisciplinary team at Aridhia collaborates closely with clinical experts to address significant health challenges, contributing to ongoing integrated care and advanced clinical research.

Exco inTouch

Venture Round in 2014
Exco inTouch Ltd is a provider of patient engagement and data capture solutions for clinical trials and healthcare programs, operating in the United Kingdom and internationally. Founded in 2004 and headquartered in Nottingham, the company offers a comprehensive application system called Gather, which facilitates two-way communication between patients, site managers, and study teams while ensuring compliance with study protocols. In addition to clinical trial support, Exco inTouch develops disease management programs that create condition-specific care plans, helping patients understand their conditions, adhere to treatment regimens, and effectively manage their health. The company's digital health platform has been applied across various therapeutic areas, including diabetes, dermatology, respiratory diseases, and haemophilia. As of December 2016, Exco inTouch operates as a subsidiary of eResearchTechnology, Inc.

Mirada Medical

Venture Round in 2014
Mirada Medical Limited specializes in the development of medical imaging software applications tailored for radiology, molecular imaging, radiation oncology, and multidisciplinary meetings in hospitals, imaging centers, and cancer centers. Founded in 1999 and headquartered in Oxford, United Kingdom, with an additional office in Denver, Colorado, the company offers a range of innovative software solutions. These include Mirada XD, which serves various medical fields such as nuclear medicine and cardiology; DLCExpert, a clinical application that provides automated organ-at-risk contouring; and Mirada IM, which supports interventional medicine products, including radioembolization therapy. Mirada Medical's products are marketed through direct sales and distributors, aiming to enhance the diagnosis, management, and treatment of cancer and other diseases worldwide.

Elateral Ltd.

Venture Round in 2014
Elateral Ltd. specializes in intelligent multi-channel content generation and customization solutions for clients in the United Kingdom and beyond. The company has developed the Elateral Marketing Services Cloud, a cloud-based platform that allows marketing organizations to source, customize, and distribute content in various formats and languages. Its offerings include professional services such as consulting, implementation, template development, and asset management, alongside solutions for customized point-of-sale materials, promotional packaging, and campaign visibility. Elateral's technology supports a marketing trend known as Mass Multi-Channel Customization, which enables marketers to deliver relevant content effectively across numerous channels. The company serves a diverse clientele, including brand marketers in consumer goods, hi-tech, and automotive industries, as well as design agencies and local marketing teams. Founded in 1995 and headquartered in Farnham, United Kingdom, Elateral Ltd. is a subsidiary of Elateral Group Limited.

Abcodia

Venture Round in 2014
Abcodia Ltd. is a company focused on the discovery and validation of molecular biomarkers for disease diagnosis and screening. Established in 2010 and based in London, it offers the Roca Test, a solution for the early detection of ovarian cancer, available to customers across various states in the United States as well as in the United Kingdom. Abcodia utilizes a unique longitudinal serum biobank and collaborates with prominent institutions and diagnostic companies to enhance the diagnostic development process. Through these efforts, the company aims to improve disease detection and contribute to better health outcomes.

MyMeds&Me

Venture Round in 2014
MyMeds&Me Ltd was formed in 2011 by Dr Andrew Rut, Dr Trevor Gibbs and Steve Powell. The founders bring together a unique blend of pharmaceutical and commercial experience, encompassing leadership of global clinical development, safety & pharmacovigilance operations, and the development and global commercialization of technology solutions for the life sciences industry. The strength of this leadership and the business case to create an industry-wide technology solution, led to significant funding being obtained from within the pharmaceutical industry itself and private equity during 2012/13.

Perpetuum

Series C in 2014
Perpetuum Ltd. specializes in the engineering, manufacturing, and commercialization of electromagnetic vibration harvesting micro generators. Founded in 2004 and based in Southampton, United Kingdom, the company focuses on creating battery-free vibration energy harvesters and wireless sensor nodes for various applications, including rail, oil and gas, chemicals, power generation, and water treatment. Perpetuum's technology converts mechanical vibrations into electrical energy, enabling autonomous, maintenance-free wireless sensors that monitor equipment conditions and processes. This innovative approach enhances efficiency and safety in fleet management and services, particularly within the rail industry. As a technology spin-off from the University of Southampton, Perpetuum has established itself as a leader in vibration energy harvesting, providing practical solutions for wireless automation.

Proveca

Venture Round in 2014
Proveca Ltd., a pharmaceutical company, identifies, researches, and licenses off-patent medicines with a focus on the pediatric market. The company’s product portfolio focuses on neurology, cardiology, immunology, analgesia, and pain management. It develops medicines for the treatment of sialorrhoea (chronic pathological drooling) and epilepsy; heart failure, haemodynamic insufficiency, and transplant rejection; and acute pain as well as for children with chronic illnesses. The company was founded in 2010 and is based in Daresbury, United Kingdom.

Cisiv

Venture Round in 2014
Cisiv Ltd is a technology solutions provider focused on serving global pharmaceutical and biotech companies, research organizations, and academic institutions. The company specializes in its Baseline Plus platform, a web-based data capture system designed for non-interventional studies. This platform simplifies the execution of complex, large-scale multinational studies by enhancing data quality and workflow through features that support data entry, online community engagement, and translation capabilities. By enabling researchers and medical professionals to extract meaningful patient data, Cisiv facilitates deeper insights into the real-world application of medical treatments and products. Established in 1995, Cisiv is headquartered in Kingston upon Thames, United Kingdom.

OmPrompt

Venture Round in 2014
OmPrompt Limited is a data management company based in Abingdon, United Kingdom, specializing in supply chain solutions. Established in 2002 and formerly known as Sparhurst Limited, the company offers an Order Management Platform that facilitates EDI connectivity and automates non-EDI document processes. This platform enhances visibility and control within order-to-cash and procure-to-pay processes, enabling suppliers to connect with any trading partner and manage various document formats. OmPrompt's advanced machine learning technology enables the automation of order processing, complaints, and fulfillment across multi-enterprise environments, allowing clients to effectively handle both structured and unstructured data from customers and suppliers. The company serves notable clients, including Unilever, BACARDI, Nestle, Kellogg's, and Targus, aiming to improve operational efficiency and customer experience while reducing costs.

Blackbay

Venture Round in 2014
Blackbay Ltd. is a provider of mobile enterprise solutions tailored for the transport and logistics industry. Founded in 2004 and headquartered in Derby, United Kingdom, the company develops various cloud-based applications, including Delivery Connect, which enables real-time freight movement management, and No Trucking Worries, designed for drivers and dispatchers. Additionally, Blackbay offers Expect, a solution that enhances communication and management during delivery and collection processes. The company serves diverse sectors, including postal services, courier operations, and manufacturing, with a customer base that includes notable names such as Royal Mail and DHL. Blackbay has empowered over 55,000 mobile workers globally, facilitating efficient supply chain and field service operations. Formerly known as iTouch Business Mobility, Blackbay operates as a subsidiary of BluJay Solutions Ltd.

Elateral Ltd.

Venture Round in 2014
Elateral Ltd. specializes in intelligent multi-channel content generation and customization solutions for clients in the United Kingdom and beyond. The company has developed the Elateral Marketing Services Cloud, a cloud-based platform that allows marketing organizations to source, customize, and distribute content in various formats and languages. Its offerings include professional services such as consulting, implementation, template development, and asset management, alongside solutions for customized point-of-sale materials, promotional packaging, and campaign visibility. Elateral's technology supports a marketing trend known as Mass Multi-Channel Customization, which enables marketers to deliver relevant content effectively across numerous channels. The company serves a diverse clientele, including brand marketers in consumer goods, hi-tech, and automotive industries, as well as design agencies and local marketing teams. Founded in 1995 and headquartered in Farnham, United Kingdom, Elateral Ltd. is a subsidiary of Elateral Group Limited.

Elateral Ltd.

Venture Round in 2014
Elateral Ltd. specializes in intelligent multi-channel content generation and customization solutions for clients in the United Kingdom and beyond. The company has developed the Elateral Marketing Services Cloud, a cloud-based platform that allows marketing organizations to source, customize, and distribute content in various formats and languages. Its offerings include professional services such as consulting, implementation, template development, and asset management, alongside solutions for customized point-of-sale materials, promotional packaging, and campaign visibility. Elateral's technology supports a marketing trend known as Mass Multi-Channel Customization, which enables marketers to deliver relevant content effectively across numerous channels. The company serves a diverse clientele, including brand marketers in consumer goods, hi-tech, and automotive industries, as well as design agencies and local marketing teams. Founded in 1995 and headquartered in Farnham, United Kingdom, Elateral Ltd. is a subsidiary of Elateral Group Limited.

Mirada Medical

Venture Round in 2014
Mirada Medical Limited specializes in the development of medical imaging software applications tailored for radiology, molecular imaging, radiation oncology, and multidisciplinary meetings in hospitals, imaging centers, and cancer centers. Founded in 1999 and headquartered in Oxford, United Kingdom, with an additional office in Denver, Colorado, the company offers a range of innovative software solutions. These include Mirada XD, which serves various medical fields such as nuclear medicine and cardiology; DLCExpert, a clinical application that provides automated organ-at-risk contouring; and Mirada IM, which supports interventional medicine products, including radioembolization therapy. Mirada Medical's products are marketed through direct sales and distributors, aiming to enhance the diagnosis, management, and treatment of cancer and other diseases worldwide.

Grapeshot

Venture Round in 2014
Grapeshot Limited is a software company that specializes in providing marketing and advertising solutions through its Contextual Intelligence Platform. Founded in 2002 and headquartered in Cambridge, United Kingdom, Grapeshot offers tools for real-time targeting, audience discovery, and data enrichment, which aid brands, media agencies, and publishers in enhancing their advertising strategies. Its services include custom targeting, predictive targeting, brand safety, GDPR compliance, and campaign analytics. The platform enables users to improve media efficiency, increase customer engagement, and elevate brand perception by leveraging actionable data to identify revenue-driving behaviors. Grapeshot has received multiple accolades for its innovations, including recognition as a leading publisher tool and attribution solution. The company operates globally, with offices in major cities such as London, New York, Chicago, Los Angeles, Singapore, Toronto, Hong Kong, Shanghai, and Sydney. In 2018, Grapeshot became a subsidiary of Oracle Corporation.

Hussle

Venture Round in 2014
Hussle is the smart new way to fit fitness into your life. We partner with amazing gyms across the UK. When you Hussle, you can go to any of these gyms. There are no contracts, no inductions, no sign-up fees. Just thousands of gyms, pools and spas – wherever you are, whenever you want to go. So when you Hussle, you can make fitness a part of your day, not a pause in it. Hussle. Make life work out.

Egress

Series A in 2014
Egress Software Technologies Ltd. specializes in cloud-based email and file encryption solutions aimed at securely sharing confidential information across various sectors, including public services, healthcare, education, and financial services. Founded in 2007 and headquartered in London, the company offers a range of products such as desktop, mobile, and gateway encryption, as well as secure web forms. Its human-layer security platform employs advanced contextual machine learning and encryption technologies to prevent data breaches, providing organizations with tools to manage unstructured data effectively. Egress aims to enhance email security, ensuring compliance with regulatory standards and improving productivity for small, mid-sized, and enterprise-level organizations. With offices in London, Sheffield, Boston, and Toronto, Egress serves a global clientele, including individual users and large commercial entities.

Abcodia

Venture Round in 2014
Abcodia Ltd. is a company focused on the discovery and validation of molecular biomarkers for disease diagnosis and screening. Established in 2010 and based in London, it offers the Roca Test, a solution for the early detection of ovarian cancer, available to customers across various states in the United States as well as in the United Kingdom. Abcodia utilizes a unique longitudinal serum biobank and collaborates with prominent institutions and diagnostic companies to enhance the diagnostic development process. Through these efforts, the company aims to improve disease detection and contribute to better health outcomes.

Cisiv

Venture Round in 2013
Cisiv Ltd is a technology solutions provider focused on serving global pharmaceutical and biotech companies, research organizations, and academic institutions. The company specializes in its Baseline Plus platform, a web-based data capture system designed for non-interventional studies. This platform simplifies the execution of complex, large-scale multinational studies by enhancing data quality and workflow through features that support data entry, online community engagement, and translation capabilities. By enabling researchers and medical professionals to extract meaningful patient data, Cisiv facilitates deeper insights into the real-world application of medical treatments and products. Established in 1995, Cisiv is headquartered in Kingston upon Thames, United Kingdom.

MyMeds&Me

Venture Round in 2013
MyMeds&Me Ltd was formed in 2011 by Dr Andrew Rut, Dr Trevor Gibbs and Steve Powell. The founders bring together a unique blend of pharmaceutical and commercial experience, encompassing leadership of global clinical development, safety & pharmacovigilance operations, and the development and global commercialization of technology solutions for the life sciences industry. The strength of this leadership and the business case to create an industry-wide technology solution, led to significant funding being obtained from within the pharmaceutical industry itself and private equity during 2012/13.

Proveca

Venture Round in 2013
Proveca Ltd., a pharmaceutical company, identifies, researches, and licenses off-patent medicines with a focus on the pediatric market. The company’s product portfolio focuses on neurology, cardiology, immunology, analgesia, and pain management. It develops medicines for the treatment of sialorrhoea (chronic pathological drooling) and epilepsy; heart failure, haemodynamic insufficiency, and transplant rejection; and acute pain as well as for children with chronic illnesses. The company was founded in 2010 and is based in Daresbury, United Kingdom.

Hussle

Seed Round in 2013
Hussle is the smart new way to fit fitness into your life. We partner with amazing gyms across the UK. When you Hussle, you can go to any of these gyms. There are no contracts, no inductions, no sign-up fees. Just thousands of gyms, pools and spas – wherever you are, whenever you want to go. So when you Hussle, you can make fitness a part of your day, not a pause in it. Hussle. Make life work out.

Workshare

Debt Financing in 2012
Workshare is a provider of secure enterprise file sharing and collaboration applications, offering an innovative platform that enables professionals to compare, protect, and share high-stakes documents across various devices. The platform allows content owners to accurately track and compare amendments made by contributors, facilitating secure collaboration and effective control over document changes. Headquartered in London, Workshare also has offices in the United States and Australia, serving over two million professionals in 70 countries.

Atego

Venture Round in 2012
Atego is a global company specializing in software tools and professional services aimed at assisting organizations in engineering complex, mission-critical systems and software. With over 30 years of experience, Atego supports major engineering sectors such as aerospace, automotive, energy, and medical industries. The company offers model-based systems engineering applications that facilitate collaboration in building digital models of intricate systems, while also managing variability and promoting reuse. Atego has been a pioneer in developing standardized solutions for various engineering methodologies and actively engages with global standards organizations in the fields of systems engineering and software development. Its longstanding relationships with clients reflect the trust in Atego's expertise and commitment to superior engineering support.

Abcodia

Venture Round in 2011
Abcodia Ltd. is a company focused on the discovery and validation of molecular biomarkers for disease diagnosis and screening. Established in 2010 and based in London, it offers the Roca Test, a solution for the early detection of ovarian cancer, available to customers across various states in the United States as well as in the United Kingdom. Abcodia utilizes a unique longitudinal serum biobank and collaborates with prominent institutions and diagnostic companies to enhance the diagnostic development process. Through these efforts, the company aims to improve disease detection and contribute to better health outcomes.

Celoxica

Venture Round in 2011
Celoxica Limited, based in Abingdon, United Kingdom, provides hardware-accelerated market data access and order execution solutions aimed at the financial services industry. Founded in 1996, the company specializes in ultra-low latency trading services, catering to the advanced trading community, including trading firms and banks engaged in high-frequency trading, market making, liquidity provision, algorithmic trading, and smart order routing. Celoxica offers a range of market data feed handlers covering major U.S. and European equities, options, futures, and foreign exchange markets. The company facilitates seamless connectivity for brokers and clients by managing inbound FIX, credit checks, and outbound native protocols to execution venues. With additional offices in Chicago and New York, Celoxica remains focused on meeting the growing demands for speed and efficiency in electronic trading.

Oxsensis

Series C in 2010
Oxsensis Ltd. is a manufacturer of non-electrical optical sensors designed for extreme environments, focusing on applications in aerospace, power generation, oil and gas, and nuclear industries. Founded in 2003 and headquartered in Didcot, United Kingdom, the company specializes in optical pressure sensor systems, temperature transducers, and optical accelerometers. Its product lineup includes the Wave-Phire Dynamic Pressure Transducer for harsh atmospheres, the i-Phire 4 Channel Optical Interrogator Unit for converting optical signals into voltage signals, and S-Phire software for combustion monitoring. These sensors provide high sensitivity and immunity to electromagnetic interference, optimizing performance in demanding conditions. Oxsensis also supports various markets, including energy production, emissions monitoring, and high-temperature equipment health monitoring, with additional offices in the United States, Russia, China, and Japan.

Opta

Venture Round in 2008
Opta Sportsdata Limited is a sports data company that collects, packages, analyses, and distributes live data. The company provides live performance data for broadcasting, betting, media, and professional sports; editorial services; data visualization services; analytical products and services; and data of leagues and competitions. It serves clients in betting, broadcast, online and mobile, and print sectors, as well as clubs and governing bodies, and sponsors and brands worldwide.

Oxsensis

Venture Round in 2007
Oxsensis Ltd. is a manufacturer of non-electrical optical sensors designed for extreme environments, focusing on applications in aerospace, power generation, oil and gas, and nuclear industries. Founded in 2003 and headquartered in Didcot, United Kingdom, the company specializes in optical pressure sensor systems, temperature transducers, and optical accelerometers. Its product lineup includes the Wave-Phire Dynamic Pressure Transducer for harsh atmospheres, the i-Phire 4 Channel Optical Interrogator Unit for converting optical signals into voltage signals, and S-Phire software for combustion monitoring. These sensors provide high sensitivity and immunity to electromagnetic interference, optimizing performance in demanding conditions. Oxsensis also supports various markets, including energy production, emissions monitoring, and high-temperature equipment health monitoring, with additional offices in the United States, Russia, China, and Japan.

Process System Enterprise

Venture Round in 2007
Process Systems Enterprise Limited is a leading provider of process modeling software and model-based innovation services tailored for the process industries. The company's flagship product, gPROMS, serves as a comprehensive modeling environment that generates predictive insights for decision support across various applications, including reaction, separation, crystallization, and biotechnology. In addition to its software solutions, the company offers a range of consultancy services focused on modeling strategy, process design, and implementation, as well as training and knowledge transfer. Its expertise extends to multiple sectors, such as chemicals, energy, pharmaceuticals, food and beverage, and industrial gases. Founded in 1997 and headquartered in London, the company also maintains offices in the United States, Japan, South Korea, and Germany, along with representation in India. By leveraging advanced process modeling, Process Systems Enterprise aims to enhance innovation, improve operational efficiency, and manage risks for its clients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.